Role of Lung Flute in Acute Exacerbation of Chronic Bronchitis in Hospitalized Chronic Bronchitis Patients
Paper ID : 1034-IPTCCU. (R1)
Authors
Radwa Nashaat Hassan *1, Nessrein Ghareeb Elnahas2, Reem Ibrahim Elkorashy2, Asmaa Mohammed sharabash3
1Researcher
2professor
3Assistant professor
Abstract
Background: Acute Exacerbation of Chronic Bronchitis (AECB) is a significant consequence of Chronic Obstructive Pulmonary Disease (COPD), leading to increased hospitalization and impaired respiratory function. Mucus retention worsens airflow limitation, reducing oxygenation. A noninvasive Oscillatory Positive Expiratory Pressure (OPEP) device called the Lung Flute was developed to enhance respiratory outcomes and mucus removal.
Aim: The purpose of this research was to assess how well the Lung Flute improved lung function, mucus clearance, and patient recovery in hospitalized AECB patients.
Methods: A total of 60 AECB patients were split into two groups and subjected to a randomized controlled study (RCT). Group A received Lung Flute therapy with breathing exercises, while Group B performed breathing exercises only. Key outcomes included arterial blood gases (ABG), oxygen saturation (SpO₂), COPD Assessment Test (CAT) scores, hospitalization duration, and symptom relief. Statistical analysis compared pre- and post-intervention results.
Result: Group A demonstrated considerable improvement in lung function and mucus clearance as compared to Group B. pH, PaO₂, SaO₂, and bicarbonate levels significantly increased (p < 0.001), while PaCO₂ levels decreased, reflecting better respiratory function. CAT and MMRC scores showed greater symptom improvement in Group A (p < 0.01). Group A had a considerably shorter hospital stay (8.07 ± 4.58 days) compared to Group B (14.30 ± 4.62 days, p = 0.001).
Conclusion: The study demonstrated that integrating the Lung Flute into AECB management significantly enhances mucus clearance, improves lung function, and reduces hospital stays, making it an effective adjunct therapy.
Keywords
Lung Flute, AECB, Airway Clearance Therapy, OPEP, COPD.
Status: Accepted